Because TXA2 is known to function through the activation of the thromboxane A2 receptor (TBXA2R), we further investigated TBXA2R expression in breast cancer and observed that the protein levels of TBXA2R in breast tumors were 5.9-fold higher than NAT (Fig. 1b). Here, BRD2 is linked to breast cancer.